1-10 of 10
A. Dimitrios Colevas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies

A. Dimitrios Colevas, Zahra Talebi, Elizabeth Winters, Caroline Even, Victor Ho-Fun Lee, Maura L. Gillison, Saad A. Khan, Rong Lu, Benjamin A. Pinsky, Samantha S. Soldan, Olga Vladmirova, Paul M. Lieberman, Troy E. Messick
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (5): 815–823.
https://doi.org/10.1158/1078-0432.CCR-24-2814
Published: 03 March 2025
View article titled, First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies
Open the PDF for First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies in another window
Includes: Supplementary data
Journal Articles

Abstract PO-005: Phase 1/2 study of Ad/PNP with fludarabine for the treatment of head & neck squamous cell carcinoma (HNSCC)

A. Dimitrios Colevas, Eric J. Sorscher, William B. Parker, Roan Courtney Raymundo, Jeong S. Hong, Regina Rab, Camilo Henao, Nikki Schmitt, Madison Stallings, Kelly T. McKee, Eben Rosenthal, Joseph Curry
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-005.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-005
Published: 15 September 2023
View article titled, Abstract PO-005: Phase 1/2 study of Ad/PNP with fludarabine for the treatment of head & neck squamous cell carcinoma (HNSCC)
Journal Articles

89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma

Yu-Jin Lee, Nynke S. van den Berg, Heying Duan, E. Carmen Azevedo, Valentina Ferri, Marisa Hom, Roan C. Raymundo, Alex Valencia, Jessa Castillo, Bin Shen, Quan Zhou, Laura Freeman, Mary Ellen Koran, Michael J. Kaplan, A. Dimitrios Colevas, Fred M. Baik, Frederick T. Chin, Brock A. Martin, Andrei Iagaru, Eben L. Rosenthal
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (20): 4425–4434.
https://doi.org/10.1158/1078-0432.CCR-22-0094
Published: 14 October 2022
View article titled, <sup>89</sup>Zr-panitumumab Combined With <sup>18</sup>F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
Open the PDF for <sup>89</sup>Zr-panitumumab Combined With <sup>18</sup>F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction

A. Dimitrios Colevas
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4171–4172.
https://doi.org/10.1158/1078-0432.CCR-22-1711
Published: 03 October 2022
View article titled, HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction
Open the PDF for HPV DNA as a Biomarker in Oropharyngeal Cancer: A Step in the Right Direction in another window
Journal Articles

Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use

Robert L. Ferris, Lisa Licitra, Jerome Fayette, Caroline Even, George Blumenschein, Jr, Kevin J. Harrington, Joel Guigay, Everett E. Vokes, Nabil F. Saba, Robert Haddad, Shanmugasundaram Ramkumar, Jeffery Russell, Peter Brossart, Makoto Tahara, A. Dimitrios Colevas, Fernando Concha-Benavente, Mark Lynch, Li Li, Maura L. Gillison
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (17): 5221–5230.
https://doi.org/10.1158/1078-0432.CCR-18-3944
Published: 03 September 2019
View article titled, Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
Open the PDF for Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use in another window
Includes: Supplementary data
Journal Articles

The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity

Stan van Keulen, Naoki Nishio, Andrew Birkeland, Shayan Fakurnejad, Brock Martin, Tim Forouzanfar, Kristen Cunanan, A. Dimitrios Colevas, Nynke S. van den Berg, Eben Rosenthal
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4656–4662.
https://doi.org/10.1158/1078-0432.CCR-19-0319
Published: 01 August 2019
View article titled, The Sentinel Margin: Intraoperative <em>Ex Vivo</em> Specimen Mapping Using Relative Fluorescence Intensity
Open the PDF for The Sentinel Margin: Intraoperative <em>Ex Vivo</em> Specimen Mapping Using Relative Fluorescence Intensity in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-cell Neoplasms

Beata Holkova, Maciej Kmieciak, E. Brent Perkins, Prithviraj Bose, Rachid C. Baz, G. David Roodman, Robert K. Stuart, Viswanathan Ramakrishnan, Wen Wan, Cody J. Peer, Jana Dawson, Loveleen Kang, Connie Honeycutt, Mary Beth Tombes, Ellen Shrader, Caryn Weir-Wiggins, Martha Wellons, Heidi Sankala, Kevin T. Hogan, A. Dimitrios Colevas, L. Austin Doyle, William D. Figg, Domenico Coppola, John D. Roberts, Daniel Sullivan, Steven Grant
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (22): 5652–5662.
https://doi.org/10.1158/1078-0432.CCR-14-0805
Published: 13 November 2014
View article titled, Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-cell Neoplasms
Open the PDF for Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-cell Neoplasms in another window
Includes: Supplementary data
Journal Articles

In vitro and In vivo Clinical Pharmacology of Dimethyl Benzoylphenylurea, a Novel Oral Tubulin-Interactive Agent

Michelle A. Rudek, Ming Zhao, Nicola F. Smith, Robert W. Robey, Ping He, Gurulingappa Hallur, Saeed Khan, Manuel Hidalgo, Antonio Jimeno, A. Dimitrios Colevas, Wells A. Messersmith, Antonio C. Wolff, Sharyn D. Baker
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8503–8511.
https://doi.org/10.1158/1078-0432.CCR-05-1037
Published: 01 December 2005
View article titled, <em>In vitro</em> and <em>In vivo</em> Clinical Pharmacology of Dimethyl Benzoylphenylurea, a Novel Oral Tubulin-Interactive Agent
Open the PDF for <em>In vitro</em> and <em>In vivo</em> Clinical Pharmacology of Dimethyl Benzoylphenylurea, a Novel Oral Tubulin-Interactive Agent in another window
Journal Articles

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-d-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Judith E. Karp, Antonino Passaniti, Ivana Gojo, Scott Kaufmann, Keith Bible, Tushar S. Garimella, Jacqueline Greer, Janet Briel, B. Douglas Smith, Steven D. Gore, Michael L. Tidwell, Douglas D. Ross, John J. Wright, A. Dimitrios Colevas, Kenneth S. Bauer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8403–8412.
https://doi.org/10.1158/1078-0432.CCR-05-1201
Published: 01 December 2005
View article titled, Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<sc>d</sc>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias
Open the PDF for Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<sc>d</sc>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias in another window
Journal Articles

HER2 Expression in Salivary Gland Carcinomas: Dependence on Histological Subtype

Bonnie Glisson, A. Dimitrios Colevas, Robert Haddad, Jeoffrey Krane, Adel El-Naggar, Merrill Kies, Rosemary Costello, Carmen Summey, Matthew Arquette, Corey Langer, Philip C. Amrein, Marshall Posner
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 944–946.
https://doi.org/10.1158/1078-0432.CCR-03-0253
Published: 10 February 2004
View article titled, HER2 Expression in Salivary Gland Carcinomas: <subtitle>Dependence on Histological Subtype</subtitle>
Open the PDF for HER2 Expression in Salivary Gland Carcinomas: <subtitle>Dependence on Histological Subtype</subtitle> in another window